Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 May 14

PMID 35563235

Authors

Marika Lanza

Alessia Filippone

Giovanna Casili

Letterio Giuffre

Sarah Adriana Scuderi

Irene Paterniti

Michela Campolo

Salvatore Cuzzocrea

Emanuela Esposito

Affiliations

Soon will be listed here.

Abstract

Migraine is a common brain-disorder that affects 15% of the population. Converging evidence shows that migraine is associated with gastrointestinal disorders. However, the mechanisms underlying the interaction between the gut and brain in patients with migraine are not clear. In this study, we evaluated the role of the short-chain fatty acids (SCFAs) as sodium propionate (SP) and sodium butyrate (SB) on microbiota profile and intestinal permeability in a mouse model of migraine induced by nitroglycerine (NTG). The mice were orally administered SB and SP at the dose of 10, 30 and 100 mg/kg, 5 min after NTG intraperitoneal injections. Behavioral tests were used to evaluate migraine-like pain. Histological and molecular analyses were performed on the intestine. The composition of the intestinal microbiota was extracted from frozen fecal samples and sequenced with an Illumina MiSeq System. Our results demonstrated that the SP and SB treatments attenuated hyperalgesia and pain following NTG injection. Moreover, SP and SB reduced histological damage in the intestine and restored intestinal permeability and the intestinal microbiota profile. These results provide corroborating evidence that SB and SP exert a protective effect on central sensitization induced by NTG through a modulation of intestinal microbiota, suggesting the potential application of SCFAs as novel supportive therapies for intestinal disfunction associated with migraine.

Citing Articles

Sodium butyrate restored TRESK current controlling neuronal hyperexcitability in a mouse model of oxaliplatin-induced peripheral neuropathic pain.

Ho I, Zou Y, Luo K, Qin F, Jiang Y, Li Q Neurotherapeutics. 2024; 22(1):e00481.

PMID: 39542827 PMC: 11742850. DOI: 10.1016/j.neurot.2024.e00481.

The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis.

Gazerani P, Papetti L, Dalkara T, Cook C, Webster C, Bai J Nutrients. 2024; 16(14).

PMID: 39064664 PMC: 11280178. DOI: 10.3390/nu16142222.

A Narrative Review of Intestinal Microbiota's Impact on Migraine with Psychopathologies.

Francavilla M, Facchetti S, Demartini C, Zanaboni A, Amoroso C, Bottiroli S Int J Mol Sci. 2024; 25(12).

PMID: 38928361 PMC: 11203823. DOI: 10.3390/ijms25126655.

Short-chain fatty acids abrogate Japanese encephalitis virus-induced inflammation in microglial cells via miR-200a-3p/ZBTB20/IKβα axis.

Majumdar A, Siva Venkatesh I, Swarup V, Basu A mBio. 2024; 15(7):e0132124.

PMID: 38869276 PMC: 11253640. DOI: 10.1128/mbio.01321-24.

Migraine and the microbiota. Can probiotics be beneficial in its prevention? - a narrative review.

Kiecka A, Szczepanik M Pharmacol Rep. 2024; 76(2):251-262.

PMID: 38502301 DOI: 10.1007/s43440-024-00584-7.

References

de Roos N, Giezenaar C, Rovers J, Witteman B, Smits M, van Hemert S . The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study. Benef Microbes. 2015; 6(5):641-6. DOI: 10.3920/BM2015.0003. View

Carabotti M, Scirocco A, Maselli M, Severi C . The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28(2):203-209. PMC: 4367209. View

Woting A, Blaut M . Small Intestinal Permeability and Gut-Transit Time Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in C3H Mice. Nutrients. 2018; 10(6). PMC: 6024777. DOI: 10.3390/nu10060685. View

Palma G, Collins S, Bercik P, Verdu E . The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?. J Physiol. 2014; 592(14):2989-97. PMC: 4214655. DOI: 10.1113/jphysiol.2014.273995. View

Sun P, Su L, Zhu H, Li X, Guo Y, Du X . Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease. Microorganisms. 2021; 9(11). PMC: 8621510. DOI: 10.3390/microorganisms9112281. View

Parada Venegas D, De la Fuente M, Landskron G, Gonzalez M, Quera R, Dijkstra G . Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019; 10:277. PMC: 6421268. DOI: 10.3389/fimmu.2019.00277. View

van Hemert S, Breedveld A, Rovers J, Vermeiden J, Witteman B, Smits M . Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol. 2014; 5:241. PMC: 4240046. DOI: 10.3389/fneur.2014.00241. View

Balan Y, Gaur A, Sakthivadivel V, Kamble B, Sundaramurthy R . Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?. Cureus. 2021; 13(11):e19740. PMC: 8684598. DOI: 10.7759/cureus.19740. View

Schilderink R, Verseijden C, de Jonge W . Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol. 2013; 4:226. PMC: 3730085. DOI: 10.3389/fimmu.2013.00226. View

10.

Schoultz I, Keita A . The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells. 2020; 9(8). PMC: 7463717. DOI: 10.3390/cells9081909. View

11.

Sensenig J, Johnson M, Staverosky T . Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev. 2001; 6(5):488-94. View

12.

Casili G, Lanza M, Filippone A, Campolo M, Paterniti I, Cuzzocrea S . Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice. J Neuroinflammation. 2020; 17(1):59. PMC: 7469611. DOI: 10.1186/s12974-020-01736-1. View

13.

Edelmayer R, Ossipov M, Porreca F . An experimental model of headache-related pain. Methods Mol Biol. 2012; 851:109-20. DOI: 10.1007/978-1-61779-561-9_7. View

14.

Bates E, Nikai T, Brennan K, Fu Y, Charles A, Basbaum A . Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. Cephalalgia. 2009; 30(2):170-8. PMC: 4854191. DOI: 10.1111/j.1468-2982.2009.01864.x. View

15.

Oleskin A, Shenderov B . Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis. 2016; 27:30971. PMC: 4937721. DOI: 10.3402/mehd.v27.30971. View

16.

Zhu X, Han Y, Du J, Liu R, Jin K, Yi W . Microbiota-gut-brain axis and the central nervous system. Oncotarget. 2017; 8(32):53829-53838. PMC: 5581153. DOI: 10.18632/oncotarget.17754. View

17.

Lanza M, Campolo M, Casili G, Filippone A, Paterniti I, Cuzzocrea S . Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury. Mol Neurobiol. 2018; 56(6):3937-3947. DOI: 10.1007/s12035-018-1347-7. View

18.

Sin Mei Tsui A, Erickson L, Mallikarjunn A, Thiessen E, Fennell C . Dual language statistical word segmentation in infancy: Simulating a language-mixing bilingual environment. Dev Sci. 2020; 24(3):e13050. DOI: 10.1111/desc.13050. View

19.

Traina G . Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases. Front Cell Neurosci. 2019; 13:345. PMC: 6682652. DOI: 10.3389/fncel.2019.00345. View

20.

Hindiyeh N, Aurora S . What the Gut Can Teach Us About Migraine. Curr Pain Headache Rep. 2015; 19(7):33. DOI: 10.1007/s11916-015-0501-4. View